From Access to Adherence: The Challenges of Antiretroviral Treatment - Studies from Botswana, Tanzania and Uganda, 2006
(2006; 320 pages) Ver el documento en el formato PDF
Índice de contenido
Ver el documentoAcknowledgments
Ver el documentoAcronyms and abbreviations
Ver el documentoForeword
Abrir esta carpeta y ver su contenido1. On hunger, transport costs and waiting time: a synthesis of challenges to ARV adherence in three African countries
Abrir esta carpeta y ver su contenido2. Overview of antiretroviral therapy, adherence and drug-resistance
Abrir esta carpeta y ver su contenido3. From training to action: the process of engaging health professionals in operational research on adherence to antiretroviral therapy
Ver el documento4. There's hope - early observations of ARV treatment roll-out in South Africa
Abrir esta carpeta y ver su contenidoFactors that facilitate or constrain adherence to antiretroviral therapy among adults at four public health facilities in Botswana: a pre-intervention study
Abrir esta carpeta y ver su contenidoA study on antiretroviral adherence in Tanzania: a pre-intervention perspective, 2005
Cerrar esta carpetaFactors that facilitate or constrain adherence to antiretroviral therapy among adults in Uganda: a pre-intervention study
Ver el documentoAcknowledgements
Ver el documentoGlossary
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenidoChapter 1: Introduction
Abrir esta carpeta y ver su contenidoChapter 2: Background to the study
Abrir esta carpeta y ver su contenidoChapter 3: Literature review
Cerrar esta carpetaChapter 4: Methodology
Ver el documento4.1 Study design
Ver el documento4.2 Study population
Ver el documento4.3 Inclusion and exclusion criteria
Ver el documento4.4 Sample size and selection
Ver el documento4.5 Data collector selection and training
Ver el documento4.6 Pilot testing
Ver el documento4.7 Data collection
Ver el documento4.8 Data analysis
Ver el documento4.9 Evaluation of methods
Ver el documento4.10 Ethical considerations
Abrir esta carpeta y ver su contenidoChapter 5: Description of the study sites
Abrir esta carpeta y ver su contenidoChapter 6: Results
Abrir esta carpeta y ver su contenidoChapter 7: Discussion, conclusions and recommendations
Ver el documentoReferences
Ver el documentoBack cover
 

4.4 Sample size and selection

A registry file from each facility's reception was used as a sampling frame from which ARV users were selected for the study, using systematic sampling. This was done to avoid bias in the sample. A total of 200 people participated in the study. Of these, 130 were ARV users interviewed through the use of one of the following tools: FGD guide, adherence tool, semi-structured interview (SSI) guide, exit interview guide, key informant interview guide and observation guide. Fifty of the study participants were community members interviewed using the FGD guide and key informant interview guide. The remaining 20 participants were staff members interviewed using the FGD guide, SSIs and the pharmacy records tool.

The study included 10 FGDs, (five with ARV users, four with community groups who were categorized by sex, and one with health workers) which helped clarify issues raised by participants. Twenty exit interviews were undertaken with ARV users to establish the quality of care, procedures and conduct while at the facility. Another 20 ART users completed adherence measurement interviews to assess levels of adherence. Two pharmacy stock records were completed.

Table 1: Summary of study participants

Tool

Public Facility Jinja Regional Referral Hospital

NGO Facility Nile Treatment Centre

Total

FGD* - staff

1x8

-

8

FGD - ARV users

3x10

2x10

50

FGD - community

2x10

2x10

40

SSI** - staff

5

5

10

SSI - ARV users

10

10

20

Key informants

10

10

20

Exit interviews

10

10

20

Adherence tool

10

10

20

Pharmacy records

1

1

2

Observations

5

5

10

Total

109

91

200

 

* Focus group discussion, ** Semi-structured interview

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013